Evidence-Based Complementary and Alternative Medicine / 2018 / Article / Tab 4 / Research Article
A Randomized Double-Blind Placebo-Controlled Trial to Evaluate Prophylactic Effect of Traditional Chinese Medicine Supplementing Qi and Hemostasis Formula on Gastrointestinal Bleeding after Percutaneous Coronary Intervention in Patients at High Risks Table 4 Comparison between patients with and without ischemic events occurrence.
Ischemic cardiac event occurred (N=8) Ischemic cardiac event absent (N=109) Statistics P valueAge -1.11(Z) 0.2655 Gender -(Fisher) 0.0245 Male N(%) 6(75.00) 36(33.03) Female N(%) 2(25.00) 73(66.97) Weight (kg) -0.40(Z) 0.6889 Height (m) 0.65(Z) 0.5158 SBP (mmHg) 1.29(Z) 0.1967 HR (beat/min) 1.00(Z) 0.3175 Smoking 2(25.00) 38(34.86) -(Fisher) 0.7137 Alcohol intake 1(12.50) 23(21.10) -(Fisher) 1.0000 Duration of smoking -1.27(Z) 0.2044 CRUSADE score 1.70(Z) 0.0896 Admitting condition -(Fisher) 1.0000 Urgent N(%) 4(50.00) 55(50.46) Selective N(%) 4(50.00) 54(49.54) Admitting diagnosis 0.7641 STEMI N(%) 2(25.00) 24(22.02) NSTEMI N(%) 3(37.50) 25(22.94) UAP N(%) 2(25.00) 39(35.78) SAP N(%) 1(12.50) 21(19.27) Medical history Hypertension N(%) 7(87.50) 80(73.39) -(Fisher) 0.6779 Type-2 DM N(%) 6(75.00) 59(54.13) -(Fisher) 0.2971 Lipid disorder N(%) 2(25.00) 26(23.85) -(Fisher) 1.0000 Chronic heart dysfunction N(%) 2(25.00) 26(23.85) -(Fisher) 1.0000 Chronic kidney dysfunction N(%) 4(50.00) 27(24.77) -(Fisher) 0.2056 Chronic bronchitis N(%) 1(12.50) 8(7.34) -(Fisher) 0.4838 Anemia N(%) 0(0.00) 4(3.67) -(Fisher) 1.0000 Prior cerebrovascular disease N(%) 1(12.50) 38(34.86) -(Fisher) 0.2659 Prior peptic ulcer N(%) 1(12.50) 7(6.42) -(Fisher) 0.4429 PCI access site -(Fisher) 0.7330 Radial artery N(%) 5(62.50) 76(69.72) Femoral artery N(%) 3(37.50) 31(28.44) Both N(%) 0(0.00) 2(1.83) Number of diseased vessel 0.39(Z) 0.6975 Single N(%) 3(37.50) 30(27.52) Double N(%) 0(0.00) 31(28.44) Multiple N(%) 5(62.50) 48(44.04) Part of diseased vessel LM N(%) 3(37.50) 15(13.76) -(Fisher) 0.1046 AD N(%) 6(75.00) 88(80.73) -(Fisher) 0.6548 CX N(%) 5(62.50) 63(57.80) -(Fisher) 1.0000 RC N(%) 7(87.50) 68(62.39) -(Fisher) 0.2557 Others N(%) 1(12.50) 16(14.68) -(Fisher) 1.0000 IABP implantation 4(50.00) 29(26.61) -(Fisher) 0.2191 Temporary cardiac pacemaker implantation 1(12.50) 6(5.50) -(Fisher) 0.3992 Number of stent implantation 0.28(Z) 0.7830 TEG 2.09(Z) 0.0366 Inhibition of ADP -2.45(Z) 0.0144 Inhibition of AA 1.17(Z) 0.2413